Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Lancet. Rheumatology|May 5, 2025
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trialVibeke Strand, Kenneth C Kalunian, Kai Wai Lee, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 18, 2024
Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOSShigeo Muro, Munehiro Seki, John R Hurst, et al.
Molecular Cancer Therapeutics|February 5, 2008
IkappaB kinase beta inhibition induces cell death in Imatinib-resistant and T315I Dasatinib-resistant BCR-ABL+ cellsElizabeth A Duncan, Christine A Goetz, Sarah J Stein, et al.
Scientific Reports|August 19, 2025
Plasma interleukin-22 concentration and disease activity in inflammatory bowel diseaseClaudia Cabrera, Daniel Fernández-Llaneza, Marita Olsson, et al.
ERJ Open Research|May 5, 2020
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPDNicola A Hanania, Alberto Papi, Antonio Anzueto, et al.
Annals of the Rheumatic Diseases|February 13, 2025
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trialsEric F Morand, Ronald van Vollenhoven, Richard A Furie, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2017
Sialic acid-to-urea ratio as a measure of airway surface hydrationCharles R Esther, David B Hill, Brian Button, et al.
Pageof 3